News

Robin Yabroff, PhD, MBA, and Michael T. Halpern, MD, PhD, MPH, examine the documentation of cost of care discussions between physicians and patients with non–small cell lung cancer and melanoma.

Dr Doshi and colleagues measured the impact of medically integrated pharmacies on prescription medication abandonment rates.

Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.

Katherine Baker, MD, and colleagues investigated how the Enhancing Oncology Model captures the performance risk and treatment costs within a disease.

On September 15, 2023, the FDA approved momelotinib for the treatment of adult patients with myelofibrosis and anemia.

Puneeth Indurlal, MD, MS, The US Oncology Network, McKesson, The Woodlands, Texas, and colleagues investigated the impact of different dosing approaches of lenalidomide on the total cost of care for patients in The US Oncology Network.

Dr Houston and colleagues assessed the care capacity and improvement strategies of pediatric institutions that care for children with cancer.

Research presented at the 2023 ASCO Quality Care Symposium revealed unequal impacts on patients from recent policy changes preventing home delivery of prescription oncology medication.

In this study, Gunjan Sharma, MS, and colleagues examine the impact of end-of-life costs on patients and caregivers, and how it influences value-based care models for physicians.

An innovative virtual consult pilot launched by Kaiser Permanente saw success in bridging the gap between oncologists and cancer subspecialists within the organization.